stockrowIndivior Pharmaceuticals Inc.
SUPN Healthcare Drug Manufacturers Specialty & Generic
Indivior Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 4.29% from fiscal 2024.
- Revenue
- +13.4%
- EPS
- +241.5%
- Free cash flow
- +240.7%
- Total debt
- +51.6%
Quarter to September 2026, against a year earlier
Follow SUPN
Alert me
Indivior Pharmaceuticals Inc. (SUPN) Gross margin
Indivior Pharmaceuticals Inc.'s gross margin over the twelve months to 30 September 2026 was 84.9%, up 4.7 percentage points from fiscal 2025 (80.2%). Over the past ten years it has ranged from 80.2% (fiscal 2025) to 90.5% (fiscal 2017) — the current reading is the lowest in ten years. That is above the Drug Manufacturers Specialty & Generic industry median of 53.5% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 80.2% | (0.41) |
| FY2024 | 80.6% | (3.52) |
| FY2023 | 84.1% | 1.73 |
| FY2022 | 82.4% | (1.59) |
| FY2021 | 83.9% | (1.07) |
| FY2020 | 85.0% | 2.84 |
| FY2019 | 82.2% | (5.09) |
| FY2018 | 87.3% | (3.22) |
| FY2017 | 90.5% | 0.59 |
| FY2016 | 89.9% | (0.54) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 85.7% | 0.25 |
| Jun 2026 | 85.4% | (1.96) |
| Mar 2026 | 87.4% | 6.15 |
| Dec 2025 | 81.2% | 7.66 |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| LQDA Liquidia Corporation compare | 92.5% |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 90.2% |
| SUPN Indivior Pharmaceuticals Inc. | 84.9% |
| ALKS Alkermes plc compare | 82.9% |
| HIMS Hims & Hers Health, Inc. compare | 68.4% |
| LNTH Lantheus Holdings, Inc. compare | 61.3% |
| RDY Dr. Reddy's Laboratories Ltd compare | 49.2% |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 40.2% |
| AMLX Amylyx Pharmaceuticals, Inc. compare | −42.7% |
| Drug Manufacturers Specialty & Generic industry median | 53.5% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on SUPN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement